Overview
- Verily, the Alphabet life‑sciences unit, filed for an Experimental Use Permit in late May to conduct phased releases in Florida and California and asked the EPA for permission to deploy up to 16 million males per state per year.
- The technique infects lab‑reared male Aedes aegypti with the naturally occurring bacterium Wolbachia so that eggs from matings with wild females do not hatch and local mosquito numbers fall over generations.
- The plan relies on automated mass‑rearing and AI‑driven sex‑sorting to prevent female releases and uses vehicle or drone distribution, and experts note male mosquitoes do not bite humans so the releases should not increase biting or disease spread.
- Coverage has questioned the proposal’s scale and timing, with some outlets describing 32 million total and others 64 million over two years, and the EPA opened a public comment window that reporting said runs through June 5 while it reviews safety claims.
- The proposal has drawn strong public and political criticism, including from Rep. Tim Burchett, even as Verily points to Fresno pilot data showing sharp local suppression; the EPA’s decision and any required local consultation will determine next steps.